Autres langues Suven Pharmaceuticals Limited Bombay S.E.

Actions

SUVENPHAR

INE03QK01018

Marché Fermé - Bombay S.E. Autres places de cotation 12:00:46 15/05/2024			Varia. 5j.	Varia. 1 janv.
649 ^INR	-0,14%		-1,01%	-10,63%

05/03	Transcript : Cohance Lifesciences Limited, Suven Pharmaceuticals Limited - M&A Call
01/03	ACTIONS INDIENNES - Les actions indiennes devraient augmenter grâce à une forte croissance intérieure et à des données sur l'inflation américaine en ligne avec les prévisions.	RE

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Suven Pharmaceuticals Limited Announces Shifting of Registered Office	27/03
Indian shares set to rise on strong domestic growth, in-line US inflation data	01/03
Suven Pharmaceuticals Limited agreed to acquire Cohance Lifesciences Limited for INR 81,340.421103 million	29/02
US FDA Clears Suven Pharmaceuticals' API and Formulations Plants in Hyderabad, India	23/02
Suven Pharmaceuticals' Consolidated Net Profit Declines in Fiscal Q3	06/02
Suven Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	05/02
Suven Pharmaceuticals CFO Steps Down	26/12
Suven Pharmaceuticals Limited Announces CFO Changes, Effective January 2, 2024	22/12
Suven Pharmaceuticals Names CFO	22/12
Suven Pharmaceuticals Limited Appoints Dr. Vetukuri Venkata Naga Kali Vara Prasada Raju as Managing Director	15/12
Suven Pharmaceuticals Limited Announces Board Appointments	15/12
Suven Pharmaceuticals Limited Approves Interim Dividend for the Financial Year 2023-24	15/12
Suven Pharmaceuticals Limited Proposes Interim Dividend for the Financial Year 2022-23	22/11
Suven Pharmaceuticals Posts Gains in Fiscal Q2 Consolidated Profit	14/11
Suven Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	09/11
Berhyanda Limited completed the acquisition of 0.001% stake in Suven Pharmaceuticals Limited for INR 1.3 million.	03/11
Suven Pharmaceuticals Limited Announces Board Changes	29/09/23
Advent International Corporation completed the acquisition of 50.1% stake in Suven Pharmaceuticals Limited from Jasti Family.	29/09/23
INDIA STOCKS-India's Nifty 50, Sensex scale new peaks on hopes of Fed rate pause	14/09/23
Indian shares set to open higher on rising hopes of a Fed rate pause	14/09/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Suven Pharmaceuticals Limited Bombay S.E.

Actions

SUVENPHAR

INE03QK01018

Autres langues

Filtres